| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 17.319 | 20.583 | 14.401 | 10.181 | 13.726 | 4.984 | 12.882 | 26.909 | 22.792 |
| Total Income - EUR | - | 17.319 | 20.583 | 14.401 | 10.181 | 14.489 | 6.195 | 12.906 | 26.927 | 36.268 |
| Total Expenses - EUR | - | 2.747 | 17.099 | 12.300 | 20.420 | 14.906 | 11.100 | 13.276 | 23.345 | 34.991 |
| Gross Profit/Loss - EUR | - | 14.571 | 3.484 | 2.101 | -10.239 | -417 | -4.905 | -369 | 3.582 | 1.277 |
| Net Profit/Loss - EUR | - | 14.052 | 2.866 | 1.669 | -10.544 | -797 | -5.051 | -749 | 2.915 | 319 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Cabinet Medical Todinca S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.065 | 13.050 | 12.336 | 10.701 | 7.588 | 5.698 | 7.218 | 11.644 | 9.742 |
| Current Assets | - | 15.174 | 11.353 | 8.892 | 3.629 | 6.875 | 2.240 | 8.574 | 10.494 | 2.178 |
| Inventories | - | 0 | 0 | 5.931 | 0 | 4 | 0 | 4.709 | 675 | 0 |
| Receivables | - | 2.686 | 1.469 | 1.175 | 2.441 | 4.151 | 1.711 | 587 | 2.561 | 60 |
| Cash | - | 12.488 | 9.884 | 1.786 | 1.188 | 2.721 | 529 | 3.278 | 7.259 | 2.118 |
| Shareholders Funds | - | 14.096 | 16.724 | 18.086 | 7.192 | 6.258 | 1.068 | 323 | 3.236 | 3.537 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.143 | 7.679 | 3.142 | 7.138 | 6.967 | 6.869 | 15.469 | 18.902 | 8.383 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 1.238 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Medical Todinca S.r.l.